Official recall notice

FDA DrugClass IINotable

FOCUS PI Hypromellose 0.7% Formula Recall (Oct 2026)

Product: FOCUS PI Hypromellose 0.7% Formula, 0.3 FL O (10 mL) per vial, STERILE, Manufactured for: Covalent Management, Inc., Manassas, VA 20109. NDC: 82724-007-19

Recall date
2026-10-07
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

Lack of Assurance of Sterility

One email a week when there are new recalls. Confirm by email; unsubscribe anytime.

Product description

Lack of Assurance of Sterility

Affected products

Batch# 6B093FI, Exp. 04/01/28; Batch# 6F511F1, Exp. 05/15/28

Verify with the official notice →
Share:

Related Recalls

2026-10-14 · FDA_DRUG
FDA Recall: Par Health and Endo USA: Argatroban Injection 250 mg/2.5 mL (100 mg/mL)
Par Health and Endo USA
2026-10-09 · FDA_DRUG
FDA Recall: Par Pharmaceutical: Brevital Sodium 500 mg/vial for Injection
Par Pharmaceutical
2026-10-07 · FDA_DRUG
FDA Recall: Benzoyl Peroxide Wash, USP, 5%, 5 FL OZ (148 mL), Distributed by: Rugby Laboratories, 17177 N. Laure
SV Labs Toronto Corporation
2026-10-07 · FDA_DRUG
FDA Recall: Estradiol Gel, 0.1%, 0.25 mg, 30-packets per carton, Rx only, Distributed by: Amneal Pharmaceuticals
Amneal Pharmaceuticals, LLC